BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16209918)

  • 1. How do CD4+CD25+ regulatory T cells control autoimmunity?
    Bluestone JA; Tang Q
    Curr Opin Immunol; 2005 Dec; 17(6):638-42. PubMed ID: 16209918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
    Yamazaki S; Inaba K; Tarbell KV; Steinman RM
    Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas.
    Piccirillo CA; d'Hennezel E; Sgouroudis E; Yurchenko E
    Curr Opin Immunol; 2008 Dec; 20(6):655-62. PubMed ID: 18926906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of T cell activation by CD4+CD25+ suppressor T cells.
    Shevach EM; Piccirillo CA; Thornton AM; McHugh RS
    Novartis Found Symp; 2003; 252():24-36; discussion 36-44, 106-14. PubMed ID: 14609210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune regulation by CD4+CD25+ regulatory T cells: implications for transplantation tolerance.
    Taams L; Vukmanovic-Stejic M; Salmon M; Akbar A
    Transpl Immunol; 2003; 11(3-4):277-85. PubMed ID: 12967781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
    Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
    Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced peripheral regulatory T cells: the family grows larger.
    Höglund P
    Eur J Immunol; 2006 Feb; 36(2):264-6. PubMed ID: 16453386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.
    Oderup C; Cederbom L; Makowska A; Cilio CM; Ivars F
    Immunology; 2006 Jun; 118(2):240-9. PubMed ID: 16771859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
    Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
    Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
    You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The blind-spot of regulatory T cells.
    Graça L; Silva-Santos B; Coutinho A
    Eur J Immunol; 2006 Apr; 36(4):802-5. PubMed ID: 16572390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells.
    Harnaha J; Machen J; Wright M; Lakomy R; Styche A; Trucco M; Makaroun S; Giannoukakis N
    Diabetes; 2006 Jan; 55(1):158-70. PubMed ID: 16380489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V; Monneaux F; Décossas M; Muller S
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?
    Curotto de Lafaille MA; Lafaille JJ
    Immunity; 2009 May; 30(5):626-35. PubMed ID: 19464985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection.
    Gorczynski RM
    Transplantation; 2006 Apr; 81(7):1027-34. PubMed ID: 16612280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent thymic origin, differentiation, and turnover of regulatory T cells.
    Mabarrack NH; Turner NL; Mayrhofer G
    J Leukoc Biol; 2008 Nov; 84(5):1287-97. PubMed ID: 18682578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity.
    Levings MK; Allan S; d'Hennezel E; Piccirillo CA
    Adv Immunol; 2006; 92():119-55. PubMed ID: 17145303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.